secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bluejay Diagnostics, Inc. (BJDX)
CIK:        0001704287
Form:       8-K
Filed at:   2023-08-28T23:59:59+00:00
Accession:  0001213900-23-071272
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bluejay Diagnostics announces $1.59M registered direct offering and warrant private placement
--------------------------------------------------------------------------------

- Company entered definitive agreement for registered direct offering of 216,000 shares at $7.365/share, raising ~$1.59M gross.
- Concurrent private placement of warrants to purchase 216,000 shares at $7.24/share, exercisable for 5 years.
- Proceeds intended for FDA approval activities, clinical studies, R&D, and general working capital.
- H.C. Wainwright & Co. acted as exclusive placement agent; closing expected August 28, 2023.
- Warrants and underlying shares sold unregistered under Section 4(a)(2) and Regulation D.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1704287/000121390023071272/0001213900-23-071272-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1704287/000121390023071272/ea184305-8k_bluejay.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-071272

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer